Chemosensitization of tumors via simultaneous delivery of STAT3 inhibitor and doxorubicin through HPMA copolymer-based nanotherapeutics with pH-sensitive activation. Nanomedicine: Nanotechnology; Biology and Medicine. 2024; 56(February 2024); 1027302024 Kovář M.Šubr V.Běhalová K.Studenovský M.Starenko D.Kovářová J.Procházková P.Etrych T.Kostka L.Zobrazit další (4) Laboratoř nádorové imunologie10.1016/j.nano.2023.102730
